Article
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
PloS one - 1 Jan 2017
Harter Philipp, Hauke Jan, Heitz Florian, Reuss Alexander, Kommoss Stefan, Marmé Frederik, Heimbach André, Prieske Katharina, Richters Lisa, Burges Alexander, Neidhardt Guido, de Gregorio Nikolaus, El-Balat Ahmed, Hilpert Felix, Meier Werner, Kimmig Rainer, Kast Karin, Sehouli Jalid, Baumann Klaus, Jackisch Christian, Park-Simon Tjoung-Won, Hanker Lars, Kröber Sandra, Pfisterer Jacobus, Gevensleben Heidrun, Schnelzer Andreas, Dietrich Dimo, Neunhöffer Tanja, Krockenberger Mathias, Brucker Sara Y, Nürnberg Peter, Thiele Holger, Altmüller Janine, Lamla Josefin, Elser Gabriele, du Bois Andreas, Hahnen Eric, Schmutzler Rita
Abstract excerpt
BACKGROUND: Identification of families at risk for ovarian cancer offers the opportunity to consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of potentially affected families in Germany was solely performed via family history and numbers of affected family members with breast or ovarian cancer. However, neither the prevalence of deleterious variants in BRCA1/2 in ovarian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.